Femgevity

What Femgevity does

Femgevity (FemGevity, Inc.) is a U.S. digital telehealth platform founded in 2022 that delivers specialized women's midlife healthcare across three care models: menopause and perimenopause, longevity and disease prevention, and gut health. Services are delivered through board-certified nurse practitioners and physicians (including Dr. Michael Abrahams, a Harvard-trained gynecologist) via telehealth, supported by an in-house diagnostic stack that combines 100+ hormone biomarkers, 200+ total biomarkers, and an AI-driven genomic panel analyzing 3,000 SNPs through Rutgers Clinical Genomics Laboratory. The platform also offers bioidentical hormone therapy, wearables (CGMs), micronutrient testing, allergy/IgG-IgE panels, and gut microbiome profiling (GI Effects Comprehensive Stool Profile via Genova Diagnostics), all coordinated through an Athenahealth-integrated patient dashboard.

The company monetizes primarily through recurring subscriptions ($79/month New Start Plan, undisclosed Hormone Balancing Plan, $495/month Longevity Plan, and $629 one-time Gut Balancing Plan), supplemented by one-time telehealth consult fees ($325 initial / $125 follow-up with Dr. Abrahams) and pass-through lab and pharmacy revenue (LabCorp, Quest, Genova, Diagnostic Solutions; CentraDrug, Curexa, CentralDrugsRx). It operates a hybrid go-to-market: B2B2C provider partnerships with OB/GYNs and primary care practices alongside direct-to-consumer telehealth available across all 50 states, with multi-state clinical delivery via three wholly-owned professional corporations (FemGevity of NJ, FL, NY).

Femgevity is privately held and appears bootstrapped — no funding rounds, parent entity, or institutional investors are disclosed. Headcount is 1–10 employees. Customer base is reported at 500+ women with 5.0-star reviews, all individual consumers, with no enterprise or employer-sponsored contracts visible. The addressable market is the global digital menopause clinic segment, sized at $1.32 billion in 2024 with a projected 16.7% CAGR through 2033. Regulatory posture includes HIPAA-compliant PHI authorization and telemedicine consent frameworks.

Name

Femgevity

Legal name

FemGevity, Inc.

Website

https://femgevityhealth.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Femgevity is a U.S. telehealth platform (founded 2022) delivering specialized menopause, longevity, and gut-health care to women through board-certified clinicians, AI-driven genomic and biomarker diagnostics, and subscription plans priced $79–$495 per month.

Ownership category

akta.pro rank

Product category

Women's Telehealth

NAICS

Offices of Physicians (6211), Medical and Diagnostic Laboratories (62151)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Sexual & Pelvic Health Telehealth (STI care, pelvic pain, endometriosis/PCOS support) (HLALAHAJ)

akta.pro secondary industries

Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD), Revenue Cycle, Coding & Telehealth Compliance Platforms (for provider orgs) (HLALABAM)

Keywords

• Menopause care services
• Telehealth consultations
• Longevity medicine
• Women's health clinic
• Precision diagnostics

Headquarters

HQ city

Hoboken

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Subscription Plans: Recurring subscription revenue from multiple care plans including New Start Plan ($79/month), Hormone Balancing Plan, Longevity Plan ($495/month), and Gut Balancing Plan ($629 one-time/3-month program). Includes monthly consultations, lab reviews, and prescription management.
2. Telehealth Consultations: One-time fees for telehealth consultations with specialists, such as Dr. Michael Abrahams at $325 for initial 45-minute consultation and $125 for follow-up visits.
3. Insurance-Covered Lab Services: Lab costs submitted to insurance; consultations are cash-pay but the company provides superbills for insurance reimbursement. This creates a hybrid revenue stream from both direct patient payments and insurance reimbursements for diagnostic services.
4. Supplement and Prescription Delivery: Revenue from convenient supplement and prescription ordering and delivery following treatment plans, including partnerships with pharmacies like CentraDrug, Curexa, and CentralDrugsRx.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

FemGevity is a digital telehealth platform delivering specialized women's healthcare focused on menopause, longevity, and gut health. The company combines board-certified medical consultations, comprehensive lab diagnostics (200+ biomarkers across hormone, gut, micronutrient, allergy, and genomic panels), AI-driven genomic analysis (3,000 SNPs), and personalized treatment plans including bioidentical hormone therapy, supplements, and prescription fulfillment. Services are delivered through a patient health portal and telehealth dashboard, available across all 50 U.S. states.

Product overview

FemGevity is a digital telehealth platform providing specialized women's health care focused on menopause, longevity, and gut health. The core platform integrates medical consultations, precision lab diagnostics, and personalized treatment plans through a patient health portal. The offering consists of three primary care models (Menopause, Longevity, and Gut Health) supported by a comprehensive telehealth dashboard and member health tracking portal. Key products include seven distinct lab tests: AI Genomic Panel (DNA analysis with AI), Genetic Cancer Screening, Gut Microbiome Test (GI Effects Comprehensive Stool Profile), Hormone Panel & Annual Bloodwork, Micronutrient Test, and Allergy & Food Explorer IgG/IgE Test. Treatment offerings include bioidentical hormones, wearables (CGM), supplements, nutraceuticals, pharmaceuticals, and complementary & alternative medicine. Subscription plans range from the New Start Plan ($79/month) to the premium Longevity Plan ($495/month), with individual consultation services available with specific providers like Dr. Michael Abrahams.

Differentiator

Problem solved

Functional benefit

Products and services

• Telehealth Platform & Patient Dashboard

Quantifiable outcome

• 85% improvement in women's longevity outcomes
• +12 more outcomes

Named customers12 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration11 records

AI capability2 records

Feature4 records

Partnerships

16 partnerships are on record, tiered core and minor.

• CentraDrug PharmaciescoreOthersPartner pharmacy for prescription fulfillment services offered through the FemGevity platform.
• CurexacoreOthersPartner pharmacy for prescription fulfillment services offered through the FemGevity platform.
• CentralDrugsRxcoreOthersPartner pharmacy for prescription fulfillment services offered through the FemGevity platform.
• LabCorpcoreTechnology or IntegrationLaboratory services provider for FemGevity's diagnostic testing including blood panels and specialized tests.
• Quest DiagnosticscoreTechnology or IntegrationLaboratory services provider for FemGevity's diagnostic testing services.
• Genova DiagnosticscoreTechnology or IntegrationSpecialized laboratory partner for comprehensive diagnostic testing including gut microbiome and functional medicine assessments.
• Diagnostic SolutionscoreTechnology or IntegrationLaboratory partner providing diagnostic testing services for the FemGevity platform.
• Rutgers Clinical Genomics Laboratory at RUCDR Infinite BiologicscoreTechnology or IntegrationUniversity-based genomics laboratory providing genetic testing and analysis services for FemGevity's AI Genomic Panel and other genetic tests.
• FemGevity of NJ P.C.coreOthersMedical group practice entity in New Jersey that provides healthcare services through the platform, employing or contracting with physicians and allied health professionals.
• FemGevity of FL P.C.coreOthersMedical group practice entity in Florida that provides healthcare services through the platform, employing or contracting with physicians and allied health professionals.
• Lenox Hill HospitalminorStrategic or Co-development PartnerLovely Abraham previously served at Lenox Hill Hospital as part of her career history before joining FemGevity.
• NYC Health and HospitalsminorStrategic or Co-development PartnerHealthcare organization where Lovely Abraham previously served as part of her career history before FemGevity.
• Elevance HealthminorStrategic or Co-development PartnerHealthcare organization where Lovely Abraham previously served before joining FemGevity.
• Sharp Memorial HospitalminorStrategic or Co-development PartnerMagnet-designated hospital where Mary Burwell previously cared for complex heart transplant patients within an interdisciplinary team.
• Designs for HealthminorOthersPartner for supplement products available through FemGevity's shop.
• Aramore SkincareminorOthersSkincare brand partner available through FemGevity's shop.

Scale indicators13 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Midi Health: Virtual care clinic specializing in perimenopause and menopause for women, offering hormone therapy and specialist consultations via telehealth — the most direct competitor to FemGevity's menopause offering.
• Evernow: Menopause-focused telehealth platform providing hormone therapy, mental health, and sleep care from clinicians — directly comparable care model and patient demographic to FemGevity.
• Elektra Health: Digital women's health platform combining virtual menopause care with education and community — competes head-to-head with FemGevity for the same perimenopausal/menopausal patient segment.
• Winona: Direct-to-consumer menopause treatment platform offering bioidentical hormone therapy and prescriptions via telehealth — overlaps with FemGevity's HRT and bioidentical hormone product lines.
• Gennev: Women's health platform focused on menopause and midlife care with telehealth visits, prescription treatments, and nutrition — directly comparable care model and target demographic.
• Alloy Women's Health: Women's telehealth platform offering menopause treatment, hormone therapy, and sexual health — overlapping service mix and direct-to-consumer subscription model.

Broad incumbents

• Maven Clinic: Large virtual women's and family health clinic covering fertility, pregnancy, postpartum, and menopause — broader scope than FemGevity but serves overlapping demographic with comparable telehealth delivery.
• Hims & Hers Health: Large direct-to-consumer telehealth platform with women's health offerings including menopause care — operates at vastly greater scale but illustrates the broader D2C telehealth model FemGevity is pursuing.
• Ro: Multi-specialty direct-to-consumer telehealth platform including women's health and hormone care — broader portfolio but comparable patient acquisition model and subscription economics.

Emerging players

• Caraway Health: Gen Z-focused women's health virtual care covering reproductive, mental, and physical health — adjacent demographic but overlapping telehealth infrastructure and care delivery model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/femgevity
• Xx.com/FemGevity
• Facebookfacebook.com/FemGevity
• LinkedInlinkedin.com/company/femgevityhealth

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Femgevity